Delta-8 THC exploded onto the scene in 2019, followed by delta-10 THC, THC-O acetate and HHC in 2020 and 2021.
While state regulatory agencies have opted for a whack-a-mole approach that focuses on controlling one cannabinoid at a time, the federal government has been largely silent on the legal status of hemp-derived cannabinoids.
Marijuana products technically aren’t eligible for federal trademarks because the plant is illegal under the Controlled Substances Act.
But that doesn’t mean cannabis businesses can’t protect their intellectual property and build brand awareness through patents and federal trademarks—the latter is applicable if the application doesn’t involve a plant-touching side of the business.
Federal immigration authorities improperly used federal drug laws to deny a visa to a software engineer at a prominent cannabis business-services provider, a judge ruled.
A three-judge U.S. appeals court has indicated it’s unlikely to side with a group of cannabis businesses aiming to overturn federal marijuana prohibition via a constitutional challenge.
“State of the Industry” panelists at MJBizCon made predictions about marijuana rescheduling, Florida, Ohio and cannabis consumption lounges.
Chad Chronister, the Florida county sheriff chosen by President-elect Donald Trump to lead the U.S. Drug Enforcement Administration, abruptly withdrew his nomination for the post Tuesday.
Historic hearings on marijuana’s status under federal law will begin in earnest sometime in mid-January, an administrative law judge for the U.S. Drug Enforcement Administration said during a procedural session Monday.
A Mississippi appeals court ruled that medical cannabis businesses in the state don’t have the right to advertise on billboards or other places because marijuana is still illegal under federal law.
Pam Bondi, the second choice of President-elect Donald Trump to lead the U.S. Justice Department, was a reliable opponent of marijuana reform while serving as Florida’s attorney general and later in the first Trump administration.
Every party that applied to argue against moving marijuana to Schedule 3 of the Controlled Substances Act has full standing to participate in an upcoming landmark hearing, a top U.S. Drug Enforcement Administration judge ruled late Tuesday.
The U.S. Drug Enforcement Administration could allow more participants to testify at upcoming hearings concerning marijuana rescheduling in addition to the initial 25 who were designated in October.
